PlainRecalls
FDA Drug Moderate Class II Terminated

Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 0591-2245-22.

Reported: March 11, 2020 Initiated: February 20, 2020 #D-0862-2020

Product Description

Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 0591-2245-22.

Reason for Recall

Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
3,695 bottles
Distribution
Nationwide in the USA.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 0591-2245-22.. Recalled by Teva Pharmaceuticals USA. Units affected: 3,695 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 11, 2020. Severity: Moderate. Recall number: D-0862-2020.